These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21443771)

  • 1. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
    Dauby N; De Wit S; Delforge M; Necsoi VC; Clumeck N
    J Int AIDS Soc; 2011 Mar; 14():16. PubMed ID: 21443771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
    Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
    BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
    Monforte Ad; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law M; De Wit S; Friis-Møller N; Phillips AN; Sabin CA; Lundgren JD;
    AIDS; 2008 Oct; 22(16):2143-53. PubMed ID: 18832878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.
    Spagnuolo V; Galli L; Salpietro S; Gianotti N; Guffanti M; Cossarini F; Bigoloni A; Cinque P; Bossolasco S; Travi G; Fumagalli L; Lazzarin A; Castagna A
    Int J Cancer; 2012 Jun; 130(12):2990-6. PubMed ID: 21796633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
    Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
    J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HIV status on prognosis of malignancies among people living with HIV in Japan.
    Ando K; Shimomura A; Watanabe K; Tsukada K; Teruya K; Gatanaga H; Shimizu C
    Cancer; 2024 Sep; 130(18):3180-3187. PubMed ID: 38718047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
    Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
    AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals.
    Long JL; Engels EA; Moore RD; Gebo KA
    AIDS; 2008 Feb; 22(4):489-96. PubMed ID: 18301061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancies in HIV: pre- and post-highly active antiretroviral therapy.
    Nutankalva L; Wutoh AK; McNeil J; Frederick WR; Reddy RB; Daftary M; Gentles A; Addae-Afoakwa K
    J Natl Med Assoc; 2008 Jul; 100(7):817-20. PubMed ID: 18672558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.
    Bedimo RJ; McGinnis KA; Dunlap M; Rodriguez-Barradas MC; Justice AC
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):203-8. PubMed ID: 19617846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
    Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
    AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
    Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
    Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.
    Bonnet F; Morlat P; Chêne G; Mercié P; Neau D; Chossat I; Decoin M; Djossou F; Beylot J; Dabis F;
    HIV Med; 2002 Jul; 3(3):195-9. PubMed ID: 12139658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
    Herida M; Mary-Krause M; Kaphan R; Cadranel J; Poizot-Martin I; Rabaud C; Plaisance N; Tissot-Dupont H; Boue F; Lang JM; Costagliola D
    J Clin Oncol; 2003 Sep; 21(18):3447-53. PubMed ID: 12972519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-AIDS-Defining Malignancies in Patients with HIV in the HAART Era.
    Nguyen ML; Farrell KJ; Gunthel CJ
    Curr Infect Dis Rep; 2010 Jan; 12(1):46-55. PubMed ID: 21308498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
    Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
    Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.
    Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; De Wit S; Phillips A; Lundgren JD; Sabin CA;
    BMC Infect Dis; 2013 Oct; 13():471. PubMed ID: 24106926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-institution retrospective study before and after the introduction of HAART.
    Franzetti M; Adorni F; Parravicini C; Vergani B; Antinori S; Milazzo L; Galli M; Ridolfo AL
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):414-20. PubMed ID: 23274934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer in HIV positive patients: the GICAT experience.
    Bearz A; Vaccher E; Martellotta F; Spina M; Talamini R; Lleshi A; Cacopardo B; Nunnari G; Berretta M; Tirelli U;
    Eur Rev Med Pharmacol Sci; 2014; 18(4):500-8. PubMed ID: 24610616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.